[Neuroprotective therapy of Alzheimer's disease?].
Mielke
R
R
Neurologische Universitätsklinik und Max-Planck-Institut für neurologische Forschung, Köln.
D000544:Alzheimer Disease / Q000517:prevention & control*; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use*; D005702:Galantamine / Q000627:therapeutic use; D006801:Humans; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D010830:Physostigmine / Q000627:therapeutic use; D010889:Piracetam / Q000627:therapeutic use; D013619:Tacrine / Q000627:therapeutic use
D002800:Cholinesterase Inhibitors; D018696:Neuroprotective Agents; D005702:Galantamine; D013619:Tacrine; D010830:Physostigmine; D010889:Piracetam